About Hansoh Pharma
Hansoh Pharma is a publicly listed company based in Shanghai (China) founded in 1995 by Huijuan Zhong. RD company focused on manufacturing of drugs for multiple therapeutic areas. The company has 8,990 employees. Its chief executive, as recorded, is Huijuan Zhong. Its website hspharm.com draws about 53 thousand monthly visits. Its focus areas include Diversified Pharmaceuticals.
Company details
Hansoh Pharma was founded in 1995 and is based in Shanghai, China. Operations are centered on research and development within the pharmaceutical sector. Drugs are manufactured for various therapeutic areas, with a focus on innovation and production processes. The company serves global markets through its domain hspharm.com, led by founder and CEO Huijuan Zhong.
- Headquarters Shanghai, China
- Employees 8,990
- Founders Huijuan Zhong
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website hspharm.com
- Social LinkedIn
- Legal Name Hansoh Pharmaceutical Group Company Limited
- Annual Revenue$1.71 B (USD)19.07as on Dec 31, 2024
- Net Profit$610.31 M (USD)30.88as on Dec 31, 2024
- EBITDA$607.74 M (USD)38.82as on Dec 31, 2024
- Employee Count8,990
People of Hansoh Pharma
1 people are tracked at Hansoh Pharma (1 in leadership); the tracked headcount is 8,990.
| Name | Role | Group |
|---|---|---|
Huijuan Zhong | Founder & CEO | Leadership |
Complete people profiles for Hansoh Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Hansoh Pharma
Hansoh Pharma is a publicly listed company on the HKEX with ticker symbol 3692 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Jun 2019
- Listed onHKG: 3692
- Listed entityHansoh Pharmaceutical Group Company Limited
- Exchange sectorHealth technology
- ISINKYG549581067
- Share price30.58 HKD (-3.04% on the day) · 2026-10-14
- Market capitalisation191,263,293,472.00 HKD
- Price to earnings24.7
- EPS (diluted, trailing year)1.24 HKD
- Dividend yield1.54%
- Volume (last session)8,624,437
Financials of Hansoh Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 16.30B HKD | 6.03B HKD | 6.30B HKD |
| 2024 | 13.29B HKD | 4.74B HKD | 4.72B HKD |
| 2023 | 11.16B HKD | 3.62B HKD | 3.40B HKD |
| 2022 | 10.91B HKD | 3.00B HKD | 3.50B HKD |
| 2021 | 11.97B HKD | 3.27B HKD | 3.83B HKD |
Detailed financial statements for Hansoh Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Hansoh Pharma
The website of Hansoh Pharma (hspharm.com) receives about 53.3K visits a month and ranks #346,881 among all websites worldwide, #291 in Biotechnology and Pharmaceuticals.
- Monthly visits53.3K
▼ 11.3% vs previous month
- Unique visitors10.2K
per month
- Global rank#346,881
among all websites
- Category rank#291
Health · Biotechnology and Pharmaceuticals
- Bounce rate22%
- Pages per visit11.9
- Average visit9 min 50 sec
- DevicesDesktop 83% · Mobile 17%
Websites whose visitors overlap most with Hansoh Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hansoh.cn | 100% | #3,059,724 | View details | ||
pfizermedicalinformation.cn | pfizermedicalinformation.cn | 80% | #2,064,072 | – | |
| qilu-pharma.com | 76% | 101.1K | #245,217 | View details | |
| sirnaomics.com | 76% | 1.9K | #8,322,653 | View details | |
| pharnexcloud.com | 76% | 51.6K | #713,781 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Hansoh Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hansoh Pharma
Complete news archive for Hansoh Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hansoh Pharma
Hansoh Pharma was founded in 1995.
Hansoh Pharma is headquartered in Shanghai, China.
Huijuan Zhong is the CEO of Hansoh Pharma, as recorded in our data. They have also founded this company.
Hansoh Pharma has 8,990 employees.
Annual revenue of Hansoh Pharma is $1.71B as on Dec 31, 2024.
Hansoh Pharma was founded in 1995 and is based in Shanghai, China. Operations are centered on research and development within the pharmaceutical sector. Drugs are manufactured for various therapeutic areas, with a focus on innovation and production processes. The company serves global markets through its domain hspharm.com, led by founder and CEO Huijuan Zhong.
Yes, Hansoh Pharma is publicly traded on HKEX under the ticker symbol 3692.